InvestorsHub Logo
Followers 3
Posts 789
Boards Moderated 0
Alias Born 01/10/2010

Re: None

Thursday, 07/28/2011 12:37:59 PM

Thursday, July 28, 2011 12:37:59 PM

Post# of 1237
Quinnradio,

I can't send private messages w/o a premium membership.

So... I feel the price has been discounted due to this:

The company said that it expects to report net revenue of approximately $12.0 million, up 104% y/y but short of analyst estimates of over $14 million. Approximately $2 million of orders received in the second quarter were unable to be shipped by June 30, primarily due to the timing of a significant change order placed by Henry Schein and the resulting last minute delays of critical components. Biolase originally planned its second quarter production and organized its supply chain accordingly, anticipating that it would continue to produce iLase systems in order to fulfill the final $3 million of the $9 million of purchase orders from Schein with the iLase system. This prepaid purchase order gives Schein certain rights and priority of delivery. Some critical components have long lead times and require orders to be placed months in advance. Schein informed the company that it was changing its order from iLase systems to a combination of the Waterlase iPlus and, to a lesser extent, the ezlase, on April 28, well after the start of the second quarter.

I know BioLases products are best in class and they are being awarded multiple patents into expanding treatment fields:

http://www.marketwatch.com/story/biolase-issued-new-patents-that-strengthen-its-expansion-into-the-treatment-of-eye-conditions-including-presbyopia-2011-07-14?reflink=MW_news_stmp

They are opening offices in India & China

They just announced: BIOLASE Reports First Orders for the BIOLASE DaVinci ImagingTM Systems for Delivery in Q-3

http://pr-usa.net/index.php?option=com_content&task=view&id=833087&Itemid=30

All of this (plus plenty of other things I didn't have time to list) points towards a promising future for BioLase.

I am just glad I got the chance to rebuy at this level.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BIOL News